International Journal of Clinical Pharmacy This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database
ConclusionThe subgroup analysis of haloperidol AEs revealed a significantly higher reporting odds ratio for TdP. Additionally, the secondary study findings suggest that women were more vulnerable to worse outcomes associated with certain AEs of FGAs. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - February 5, 2024 Category: Drugs & Pharmacology Source Type: research

Pharmacists working in residential aged care: a survey of pharmacist interest and perceived preparedness
ConclusionPharmacists reported they are interested and feel prepared to work as on-site aged care pharmacists. These findings will inform the roll-out of this new model of care to enhance multidisciplinary collaboration in residential aged care.Graphical Abstract (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - February 5, 2024 Category: Drugs & Pharmacology Source Type: research

Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database
ConclusionPsychiatric adverse events comprised only 1.2% of the total reports for semaglutide, liraglutide, and tirzepatide. However, the severity and fatal outcomes of some of these reports warrant further investigation. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - January 24, 2024 Category: Drugs & Pharmacology Source Type: research

Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database
ConclusionThis study identified potential new and unexpected AE signals of teprotumumab. Our findings emphasize the importance of pharmacovigilance analysis in the real world to identify and manage AEs effectively, ultimately improving patient safety during teprotumumab treatment. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - January 20, 2024 Category: Drugs & Pharmacology Source Type: research

Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system
ConclusionThis pharmacovigilance study identified several potential adverse events signals related to tremelimumab including some adverse events not listed on the drug label. However, further basic and clinical research studies are needed to validate these results. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - January 20, 2024 Category: Drugs & Pharmacology Source Type: research

Comparison of the sensitivities of pharmacotherapy-related and disease-specific quality of life measures in response to pharmacist-led pharmaceutical care for cancer outpatients: a randomised controlled trial
ConclusionThe PROMPT-QoL is more sensitive to detect HRQoL when delivering pharmacist-led pharmaceutical care to cancer outpatients.Trial registration: TCTR20210809008. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - January 19, 2024 Category: Drugs & Pharmacology Source Type: research

A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases
ConclusionThis study is the first to show comprehensively the disparities in the AE profiles of palbociclib and abemaciclib. The findings highlight the importance of considering these differences when selecting a suitable CDK4/6 inhibitor to ensure safe and favourable outcomes for patients with breast cancer. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - January 19, 2024 Category: Drugs & Pharmacology Source Type: research

Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach
ConclusionConsensus has been reached on one pharmaceutical care bundle and sixteen outcomes to monitor clinical pharmacy service delivery. The next step is to measure the extent of pharmaceutical care bundle delivery and the link to patient outcomes. (Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - January 19, 2024 Category: Drugs & Pharmacology Source Type: research

Thank you from the Editor-in-Chief
(Source: International Journal of Clinical Pharmacy)
Source: International Journal of Clinical Pharmacy - January 19, 2024 Category: Drugs & Pharmacology Source Type: research